Thor Medical ASA (LON:0R6Y)

London · Delayed Price · Currency is GBP · Price in NOK

6.07

+0.18 (3.06%)

At close: Aug 11, 2026

152.39% (1Y)

Market Cap	171.12M +181.5%
Revenue (ttm)	61.84K
Net Income	-4.28M
EPS	-0.01
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	197,153
Open	5.88
Previous Close	5.89
Day's Range	5.90 - 6.10
52-Week Range	2.42 - 6.10
Beta	-0.23
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 28, 2026

About Thor Medical ASA

Thor Medical ASA produces and supplies alpha-particle emitters for cancer therapy in Norway. It offers thorium-228, as well as radium-224 and lead-212 to radiopharmaceutical customers. The company was incorporated in 2009 and is headquartered in Oslo, Norway. [Read more]

Industry Biological Products, Except Diagnostic Substances

Founded 2009

Country Norway

Stock Exchange London Stock Exchange

Ticker Symbol 0R6Y

Financial Performance

Financial numbers in NOK Financial Statements

News

Thor Medical ASA Earnings Call Transcript: H2 2025

AlphaOne remains on track for completion and production ramp-up, supported by a NOK 850 million order backlog and strong market demand for alpha-emitting isotopes. The company is fully funded to reach cash-positive operations by 2027, with significant revenue potential and a growing customer base.

5 months ago - Transcripts

Thor Medical ASA Annual report: H2 2025

Thor Medical ASA has published its H2 2025 annual report on February 26, 2026.

5 months ago - Filings

Thor Medical ASA Quarterly report: H2 2025

Thor Medical ASA has published its H2 2025 quarterly earnings report on February 26, 2026.

5 months ago - Filings

Thor Medical ASA Slides: H2 2025

Thor Medical ASA has posted slides in relation to its H2 2025 quarterly earnings report, which was published on February 26, 2026.

5 months ago - Filings

Thor Medical ASA Earnings Call Transcript: H1 2025

First commercial sales and major strategic agreements validate technology and market position. AlphaOne plant is fully funded, on schedule for 2026, and capacity was expanded by 40% after a successful capital raise. Revenue potential is strong, with a NOK 770 million order backlog and ambitious growth plans.

1 year ago - Transcripts

Thor Medical ASA Quarterly report: H1 2025

Thor Medical ASA has published its H1 2025 quarterly earnings report on August 29, 2025.

1 year ago - Filings

Thor Medical ASA Slides: H1 2025

Thor Medical ASA has posted slides in relation to its H1 2025 quarterly earnings report, which was published on August 29, 2025.

1 year ago - Filings